Somatic transposition in the brain has the potential to influence the biosynthesis of metabolites involved in Parkinson's disease and schizophrenia

Biol Direct. 2012 Nov 23:7:41. doi: 10.1186/1745-6150-7-41.

Abstract

It has been recently discovered that transposable elements show high activity in the brain of mammals, however, the magnitude of their influence on its functioning is unclear so far. In this paper, I use flux balance analysis to examine the influence of somatic retrotransposition on brain metabolism, and the biosynthesis of its key metabolites, including neurotransmitters. The analysis shows that somatic transposition in the human brain can influence the biosynthesis of more than 250 metabolites, including dopamine, serotonin and glutamate, shows large inter-individual variability in metabolic effects, and may contribute to the development of Parkinson's disease and schizophrenia.

Reviewers: This article was reviewed by Dr Kenji Kojima (nominated by Dr Jerzy Jurka) and Dr Eugene Koonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / metabolism*
  • Computational Biology
  • DNA Transposable Elements*
  • Dopamine / biosynthesis
  • Dopamine / metabolism
  • Glutamic Acid / biosynthesis
  • Glutamic Acid / metabolism
  • Humans
  • Neurotransmitter Agents / biosynthesis*
  • Neurotransmitter Agents / metabolism
  • Organ Specificity
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism*
  • Schizophrenia / genetics*
  • Schizophrenia / metabolism*
  • Serotonin / biosynthesis
  • Serotonin / metabolism

Substances

  • DNA Transposable Elements
  • Neurotransmitter Agents
  • Serotonin
  • Glutamic Acid
  • Dopamine